Kayne Anderson Rudnick Investment Management LLC boosted its holdings in HealthEquity, Inc. (NASDAQ:HQY – Free Report) by 1.5% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 581,529 shares of the company’s stock after acquiring an additional 8,594 shares during the quarter. Kayne Anderson Rudnick Investment Management LLC owned about 0.67% of HealthEquity worth $50,128,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Rise Advisors LLC acquired a new stake in shares of HealthEquity during the 1st quarter valued at $28,000. Cape Investment Advisory Inc. acquired a new stake in shares of HealthEquity during the fourth quarter worth $27,000. International Assets Investment Management LLC purchased a new stake in shares of HealthEquity during the second quarter valued at $35,000. YHB Investment Advisors Inc. acquired a new position in shares of HealthEquity in the 1st quarter valued at $40,000. Finally, Fidelis Capital Partners LLC purchased a new position in HealthEquity in the 1st quarter worth about $42,000. 99.55% of the stock is owned by institutional investors and hedge funds.
HealthEquity Stock Performance
NASDAQ HQY opened at $79.53 on Friday. HealthEquity, Inc. has a twelve month low of $61.81 and a twelve month high of $88.26. The company has a quick ratio of 4.10, a current ratio of 4.10 and a debt-to-equity ratio of 0.51. The stock has a market cap of $6.92 billion, a P/E ratio of 86.45, a PEG ratio of 1.19 and a beta of 0.52. The company’s 50-day simple moving average is $76.17 and its 200 day simple moving average is $79.32.
Analyst Ratings Changes
Read Our Latest Report on HealthEquity
Insider Activity
In other HealthEquity news, Vice Chairman Stephen Neeleman sold 35,000 shares of the company’s stock in a transaction on Thursday, July 25th. The stock was sold at an average price of $79.86, for a total value of $2,795,100.00. Following the sale, the insider now directly owns 89,769 shares in the company, valued at $7,168,952.34. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In other HealthEquity news, Vice Chairman Stephen Neeleman sold 35,000 shares of the company’s stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $79.86, for a total transaction of $2,795,100.00. Following the sale, the insider now directly owns 89,769 shares of the company’s stock, valued at $7,168,952.34. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Frank Corvino sold 7,705 shares of the business’s stock in a transaction that occurred on Monday, July 8th. The stock was sold at an average price of $81.89, for a total value of $630,962.45. Following the completion of the transaction, the director now directly owns 6,070 shares in the company, valued at $497,072.30. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 75,031 shares of company stock worth $6,103,625. Company insiders own 2.20% of the company’s stock.
HealthEquity Profile
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Read More
- Five stocks we like better than HealthEquity
- 3 Warren Buffett Stocks to Buy Now
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- MarketBeat Week in Review – 9/16 – 9/20
- The Risks of Owning Bonds
- Don’t Miss These 3 Retail Stocks for Fall Gains
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.